Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NRC HEALTH
Report date December 31, 2024 · Filed April 10, 2025
Section 16 reporting ended · disclosed 2025-04-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Amandla, LLC | 0 |
Reported balance
After 2024-12-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-12-31 · Gift · Disposed 4,755,317 · Balance 0 F1: On December 31, 2024, Amandla MK Trust was decanted to Common Property Trust. As a result, Common Property Trust became the sole owner of Amandla, LLC. The 4,755,317 shares held by Amandla, LLC as of December 31, 2024, reflects that 923,955 shares were transferred from Amandla II, LLC (then an indirect wholly owned subsidiary of Amandla MK Trust) to Amandla, LLC on April 5, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 31, 2024, Amandla MK Trust was decanted to Common Property Trust. As a result, Common Property Trust became the sole owner of Amandla, LLC. The 4,755,317 shares held by Amandla, LLC as of December 31, 2024, reflects that 923,955 shares were transferred from Amandla II, LLC (then an indirect wholly owned subsidiary of Amandla MK Trust) to Amandla, LLC on April 5, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2021 Filed Mar 4, 2021 22:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 57,527 | $54.18 | $3,116,617.27 |
DisclosureSEC source: 0001567619-21-005664 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,364,018 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $54.00 to $54.525, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:36 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 3,000 | $70.11 | $210,332.10 |
DisclosureSEC source: 0001567619-20-004310 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,421,545 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.08 to $70.12, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 21:09 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,500 | $70.25 | $105,375.00 |
DisclosureSEC source: 0001567619-20-002550 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,424,545 Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:09 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 300 | $70.03 | $21,009.51 |
DisclosureSEC source: 0001567619-20-002550 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,426,045 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.00 to $70.095, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:23 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 22,160 | $70.13 | $1,554,151.71 |
DisclosureSEC source: 0001567619-20-002313 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,426,345 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.00 to $70.50, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 21,350 | $70.08 | $1,496,216.54 |
DisclosureSEC source: 0001567619-20-002091 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,448,505 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.005 to $70.575, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 21:51 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,252 | $70.05 | $648,057.27 |
DisclosureSEC source: 0001567619-20-001741 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,469,855 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.00 to $70.1625, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 21:31 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,009 | $70.04 | $70,674.30 |
DisclosureSEC source: 0001567619-20-001635 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,479,107 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.035 to $70.125, inclusive. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:31 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,635 | $70.09 | $324,877.81 |
DisclosureSEC source: 0001567619-20-001635 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,480,116 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.00 to $70.565, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:34 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,930 | $70.05 | $345,351.92 |
DisclosureSEC source: 0001567619-20-001511 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,484,751 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.00 to $70.125, inclusive. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:34 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,900 | $70.11 | $203,307.98 |
DisclosureSEC source: 0001567619-20-001511 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,489,681 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $70.00 to $70.11, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:19 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 200 | $68.00 | $13,600.00 |
DisclosureSEC source: 0001567619-20-001014 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,492,581 Read SEC document |
| January 09, 2020 Filed Jan 10, 2020 21:29 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,076 | $68.15 | $345,915.69 |
DisclosureSEC source: 0001567619-20-000897 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,492,781 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $68.00 to $68.7675, inclusive. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:29 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,200 | $68.04 | $81,647.04 |
DisclosureSEC source: 0001567619-20-000897 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,497,857 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $68.00 to $68.20, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:33 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,825 | $68.16 | $192,545.50 |
DisclosureSEC source: 0001567619-20-000784 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,499,057 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $68.00 to $68.25, inclusive. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:33 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,797 | $68.36 | $396,304.37 |
DisclosureSEC source: 0001567619-20-000784 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,501,882 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $68.00 to $68.49, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 21:51 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 10,000 | $68.05 | $680,525.00 |
DisclosureSEC source: 0001567619-19-023610 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,507,679 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $68.005 to $68.165, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within this range. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:13 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,400 | $63.94 | $89,514.32 |
DisclosureSEC source: 0001567619-19-022667 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,517,679 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.785 to $64.25, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within this range. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 21:40 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,853 | $63.96 | $310,417.29 |
DisclosureSEC source: 0001567619-19-022460 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,519,079 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.79 to $64.61, inclusive. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:40 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,600 | $64.01 | $166,433.02 |
DisclosureSEC source: 0001567619-19-022460 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,523,932 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.85 to $64.335, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 16:04 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,496 | $64.07 | $95,853.66 |
DisclosureSEC source: 0001567619-19-022341 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,526,532 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.75 to $64.285, inclusive. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 16:04 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,445 | $63.95 | $284,249.30 |
DisclosureSEC source: 0001567619-19-022341 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,528,028 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.75 to $64.11, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:37 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 235 | $64.26 | $15,099.95 |
DisclosureSEC source: 0001567619-19-022192 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,532,473 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.10 to $64.37, inclusive. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 21:37 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,565 | $63.81 | $99,869.69 |
DisclosureSEC source: 0001567619-19-022192 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,532,708 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.75 to $63.935, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 15:48 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 6,200 | $63.15 | $391,531.24 |
DisclosureSEC source: 0001567619-19-018578 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 6,534,273 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $62.98 to $63.4275. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 13:25 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 500,000 | $60.50 | $30,252,050.00 |
DisclosureSEC source: 0001567619-19-018514 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 6,540,473 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $60.50 to $63.13. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 15:14 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,063 | $64.85 | $68,932.15 |
DisclosureSEC source: 0001567619-19-017932 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,040,473 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.75 to $64.99. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 13:28 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 33,800 | $64.84 | $2,191,544.68 |
DisclosureSEC source: 0001567619-19-017819 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,041,536 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.75 to $65.255. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 15:13 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,800 | $64.89 | $181,702.92 |
DisclosureSEC source: 0001567619-19-017712 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,075,336 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.75 to $65.12. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 14:50 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 252,000 | $63.00 | $15,876,428.40 |
DisclosureSEC source: 0001567619-19-017651 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,078,136 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $63.00 to $63.62. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 14:00 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 100 | $64.80 | $6,480.00 |
DisclosureSEC source: 0001567619-19-017506 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,330,136 Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 14:00 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 12,548 | $64.83 | $813,429.12 |
DisclosureSEC source: 0001567619-19-017506 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,330,236 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.75 to $65.11. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 14:58 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 900 | $64.50 | $58,050.00 |
DisclosureSEC source: 0001567619-19-017401 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,342,784 Read SEC document |
| August 19, 2019 Filed Aug 19, 2019 22:07 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 12,198 | $64.68 | $788,943.46 |
DisclosureSEC source: 0001567619-19-017296 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,343,684 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.50 to $66.01. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:40 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 3,763 | $64.74 | $243,623.02 |
DisclosureSEC source: 0001567619-19-017240 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,355,882 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.50 to $65.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 14:11 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,400 | $64.97 | $90,960.52 |
DisclosureSEC source: 0001567619-19-017145 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,359,645 F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.725 to $65.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 14:11 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 17,600 | $64.70 | $1,138,711.20 |
DisclosureSEC source: 0001567619-19-017145 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,361,045 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $64.50 to $65.26. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 22:06 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 1,884,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018978 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner BEANS PATRICK E · CIK 0001247187 · Director · CFO and Secretary Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,378,645 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 22:06 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 1,884,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018978 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner BEANS PATRICK E · CIK 0001247187 · Director · CFO and Secretary Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:56 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 1,884,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018974 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 7,378,645 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:56 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 1,884,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018974 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 14:33 UTC | NRC HEALTH NRCIA/B · Entity 5534 | PurchaseClass A Common Stock | 5,494,440 | $19.31 | $106,097,636.40 |
DisclosureSEC source: 0001140361-18-008925 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner BEANS PATRICK E · CIK 0001247187 · Director · CFO and Secretary Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla II, LLC Disclosed balance after: 5,494,440 F1 · kind: Shares were indirectly purchased via the issuance of a promissory note. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.